secnidazole has been researched along with Vaginal Discharge in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koltun, W; Morgan, FG; Nyirjesy, P; Schwebke, JR | 1 |
Chavoustie, SE; Gersten, JK; Samuel, MJ; Schwebke, JR | 1 |
Andrade, WS; Bezerra, MM; Cavalcanti, PP; Cunha, GH; Fechine, FV; Frota Bezerra, FA; Moraes, ME; Moraes, MO; Pontes, AV | 1 |
3 trial(s) available for secnidazole and Vaginal Discharge
Article | Year |
---|---|
A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis.
Topics: Administration, Oral; Adolescent; Adult; Antiprotozoal Agents; Candidiasis, Vulvovaginal; Diarrhea; Double-Blind Method; Female; Headache; Humans; Metronidazole; Middle Aged; Nausea; Treatment Outcome; Vaginal Discharge; Vaginosis, Bacterial; Young Adult | 2017 |
A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 g for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial Vaginosis.
Topics: Administration, Oral; Adolescent; Adult; Antiprotozoal Agents; Female; Humans; Metronidazole; Prospective Studies; Treatment Outcome; United States; Vaginal Discharge; Vaginosis, Bacterial; Young Adult | 2018 |
Efficacy of the Mentha crispa in the treatment of women with Trichomonas vaginalis infection.
Topics: Adult; Antitrichomonal Agents; Double-Blind Method; Dyspareunia; Dysuria; Female; Humans; Male; Mentha; Metronidazole; Middle Aged; Nausea; Pelvic Pain; Phytotherapy; Plant Extracts; Pruritus; Statistics, Nonparametric; Taste Disorders; Trichomonas vaginalis; Trichomonas Vaginitis; Vaginal Discharge; Young Adult | 2012 |